Acting at its receptor on αvβ3, thyroid hormone (L-thyroxine, T4; 3,5,3′-triiodo-L-thyronine, T3) has been shown to be pro-angiogenic [12, 20, 51] and to induce proliferation in a variety of human cancer cells. Here, TG is linked to cancer.